-+ 0.00%
-+ 0.00%
-+ 0.00%

*Organon Acquires TOFIDENCE(TM) (tocilizumab-bavi), A Commercialized Biosimilar To ACTEMRA(R) (tocilizumab) Injection, For Intravenous Infusion In The U.S. >OGN

Dow Jones·04/01/2025 11:30:00

Please log in to view news